Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Properly Label Resident Medication Following Order Change

Meyersdale, Pennsylvania Survey Completed on 07-31-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that medications were properly labeled for one resident. According to the facility's policy, all medications and biologicals must be labeled in accordance with state and federal regulations, including appropriate instructions and precautions. For one resident, physician's orders indicated a specific dosing schedule for Gabapentin, requiring two 300 mg capsules daily and one 300 mg capsule at bedtime. However, during a medication administration observation, it was found that the label on the resident's blister pack for Gabapentin did not match the current physician's orders. The blister pack label instead indicated a different dosing schedule, with one 300 mg capsule daily and two 300 mg capsules at bedtime. An interview with the LPN administering the medication confirmed the discrepancy between the medication label and the resident's current orders. The LPN also acknowledged that a "change in direction sticker" should have been present on the blister pack to alert staff to the updated orders. The DON further confirmed that the absence of this sticker was a failure to follow proper labeling procedures, as required by facility policy and regulations.

Plan Of Correction

R37 medication label was corrected immediately at the time of survey. R37 no longer resides at facility. Re-education will be conducted by the Director of Nursing for all licensed staff on the need to ensure that any labels needed for medication direction change are put onto the medication card. Medication direction change orders were reviewed to ensure all previous direction changes are correct on the medication labels. Medication change orders will be reviewed daily during Morning Meeting (M-F) and labels verified for accuracy by the Director of Nursing or designee. A pharmacy representative will be included in the ongoing audits and will assist with audits of the medication change orders and medication labels during monthly reviews. The audit outcomes will be presented to the Quality Assurance Committee for review and recommendations.

An unhandled error has occurred. Reload 🗙